Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The investment will enable the company to enter European markets as well as enhance margins in current markets
Sanjeev is currently the Country President for AstraZeneca Malaysia
To focus on providing safer burn treatments for women and armed forces
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Subscribe To Our Newsletter & Stay Updated
